ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MEDX Horizon Kinetics Medical ETF

27.8521
0.3621 (1.32%)
After Hours
Last Updated: 16:30:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 215
Bid Price 13.97
Ask Price 31.20
News -
Day High 27.90

Low
27.0213

52 Week Range

High
32.16

Day Low 27.78
Company Name Etf Ticker Symbol Market Type
Horizon Kinetics Medical ETF MEDX NASDAQ Exchange Traded Fund
  Price Change Change Percent Etf Price Last Traded
0.3621 1.32% 27.8521 16:30:00
Open Price Low Price High Price Close Price Prev Close
27.90 27.78 27.90 27.8521 27.49
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10 215  27.82  5,982 - 27.0213 - 32.16
Last Trade Time Type Quantity Etf Price Currency
16:00:00 100  27.8521 USD

Horizon Kinetics Medical ETF Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 17.27M - - - 21.37
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Horizon Kinetics Medical...

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No MEDX Message Board. Create One! See More Posts on MEDX Message Board See More Message Board Posts

MEDX Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week27.6727.9027.3227.494740.18210.66%
1 Month29.7429.9927.3228.631,198-1.89-6.35%
3 Months28.4330.6227.3229.21816-0.5779-2.03%
6 Months28.3530.6227.021328.661,110-0.4979-1.76%
1 Year31.3132.1627.021329.621,146-3.46-11.04%
3 Years31.1032.6527.021329.871,312-3.25-10.44%
5 Years31.1032.6527.021329.871,312-3.25-10.44%

Horizon Kinetics Medical ETF seeks to provide long-term growth of capital. The Fund is an actively-managed exchange-traded fund (ETF) that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks (such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and International Depositary Receipts (IDRs)) of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries, generally, with an emphasis toward companies engaged in cancer research and drug development, such as pharmaceutical development companies, surgical and medical instrument manufacturers and developers, pharmaceutical manufacturers, and biotech and medical research companies.

Your Recent History

Delayed Upgrade Clock